Recursion Pharmaceuticals Ratios (2020-2025) | RXRX

Ratios Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Profitability
Gross Margin -46.24%-85.39%-17.09%20.74%-2.59%14.84%-3.27%9.27%19.05%36.19%53.69%-181.43%-48.04%-4.88%-183.81%
EBT Margin -30,571.67%-9,794.09%-2,192.59%-950.61%-1,189.85%-1,605.69%-1,831.18%-2,564.55%-1,049.71%-862.54%-475.48%-445.91%-538.38%-696.43%-883.10%-891.18%-668.06%-680.19%-366.82%-3,935.31%-1,374.33%-894.23%-3,135.27%
EBIT Margin -30,571.67%-9,794.09%-2,192.59%-950.61%-1,189.85%-1,605.69%-1,831.18%-2,564.55%-1,049.71%-862.54%-475.48%-445.91%-575.78%-741.72%-945.12%-908.36%-698.42%-697.39%-377.10%-4,042.41%-1,297.85%-916.75%-3,327.57%
EBITDA Margin -30,571.67%-9,794.09%-2,192.59%-950.61%-1,189.85%-1,605.69%-1,831.18%-2,564.55%-1,049.71%-862.54%-475.48%-445.91%-538.38%-696.43%-883.10%-908.36%-662.41%-676.56%-367.46%-4,042.41%-1,297.85%-916.75%-3,327.57%
Operating Margin -30,571.67%-9,794.09%-2,192.59%-950.61%-1,189.85%-1,605.69%-1,831.18%-2,564.55%-1,049.71%-862.54%-475.48%-445.91%-575.78%-741.72%-945.12%-908.36%-698.42%-697.39%-377.10%-4,042.41%-1,297.85%-916.75%-3,327.57%
Net Margin -30,571.67%-9,794.09%-2,192.59%-950.61%-1,189.85%-1,605.69%-1,831.18%-2,564.55%-1,049.71%-862.54%-475.48%-445.91%-538.38%-696.43%-883.10%-853.88%-662.41%-676.56%-367.46%-3,935.46%-1,373.26%-894.23%-3,135.32%
FCF Margin -30,835.00%-9,318.82%-1,978.73%181.57%-1,958.27%-1,563.95%-1,687.21%-2,590.68%1,369.70%-1,017.70%-477.23%-385.54%-646.87%-648.41%-699.37%-699.15%-789.86%-578.49%-244.56%-2,567.71%-907.35%-413.92%-2,272.52%
Efficiency
Assets Average 285.26M485.27M678.60M634.48M672.33M703.42M642.02M656.41M664.33M647.03M648.76M642.26M605.77M666.85M751.18M1,087.55M1,376.92M1,303.79M1,350.94M
Equity Average -219.66M204.84M620.87M570.99M518.25M465.57M412.81M436.92M457.99M449.57M453.46M450.70M432.29M492.80M554.50M779.67M984.36M926.55M983.05M
Invested Capital -206.29M-233.03M642.71M599.03M542.94M493.57M437.58M388.03M485.81M430.18M468.96M437.97M463.48M401.15M592.56M532.78M1,043.21M942.53M927.90M1,055.87M
Asset Utilization Ratio 0.020.020.020.020.020.030.040.060.070.080.070.070.080.070.090.050.040.050.03
Leverage & Solvency
Debt to Equity -0.06-0.040.010.000.000.000.000.000.000.000.000.000.000.000.050.050.030.030.020.02
Debt Ratio 0.040.040.010.000.000.000.000.000.000.000.000.000.000.000.040.040.020.020.020.01
Equity Ratio -0.69-0.860.920.910.890.670.650.630.690.690.700.690.710.720.750.720.710.720.710.75
Valuation
Enterprise Value -264.13M-219.13M5,500.74M3,297.89M2,378.29M631.63M884.70M1,384.80M910.28M801.07M1,027.73M1,259.67M1,741.11M2,039.97M1,306.35M1,423.30M1,340.30M1,623.00M1,528.65M1,455.69M
Market Capitalization 6,143.71M3,876.80M2,894.85M1,222.74M1,400.14M1,841.54M1,461.47M1,275.52M1,436.92M1,649.25M2,135.91M2,339.49M1,782.48M1,852.51M1,937.69M2,126.53M2,056.87M2,118.66M
Return Ratios
Return on Sales -21.36%-14.97%-13.53%-13.87%-17.96%-16.08%-12.92%-8.70%-6.17%-5.47%-5.31%-6.25%-7.36%-7.66%-7.55%-5.80%-7.88%-9.61%-10.05%-16.38%
Return on Capital Employed -0.37%-0.26%-0.23%-0.31%-0.36%-0.38%-0.45%-0.44%-0.45%-0.52%-0.56%-0.64%-0.71%-0.68%-0.61%-0.53%-0.46%-0.57%-0.61%
Return on Invested Capital -0.69%-0.61%-0.58%
Return on Assets -0.34%-0.25%-0.21%-0.29%-0.31%-0.33%-0.39%-0.37%-0.38%-0.41%-0.46%-0.51%-0.58%-0.56%-0.50%-0.43%-0.42%-0.50%-0.53%
Return on Equity 0.44%-0.58%-0.23%-0.32%-0.40%-0.50%-0.60%-0.56%-0.56%-0.59%-0.65%-0.73%-0.82%-0.76%-0.68%-0.59%-0.58%-0.70%-0.73%